BCR-ABL-IN-11
BCR-ABL-IN-11 (Compound 2) is a BCR-ABL inhibitor. BCR-ABL-IN-11 shows anticancer activity against chronic myelogenous leukemia (CML) (IC50 of 129.61 μM for K562 cells) [1].
Product Specifications
CAS Number
[2362-25-6]
UNSPSC
12352211
Target
Bcr-Abl
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
O=C(C1=CC=C(C=C1)N)NC2=CC=CC(NC(C3=CC=C(C=C3)N)=O)=C2
Molecular Formula
C20H18N4O2
Molecular Weight
346.38
References & Citations
[1]Peng H, et al. Identification of novel inhibitors of BCR-ABL tyrosine kinase via virtual screening. Bioorg Med Chem Lett. 2003 Nov 3;13 (21) :3693-9.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1478474-01 0.02 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YGL123C-A (YGL123C-A)
Ask
View Details MBS1478474-02 0.1 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YGL123C-A (YGL123C-A)
Ask
View Details MBS1478474-03 0.02 mg (Yeast)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YGL123C-A (YGL123C-A)
Ask
View Details 
MBS1478474-04 0.1 mg (Yeast)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YGL123C-A (YGL123C-A)
Ask
View Details MBS1478474-05 0.02 mg (Baculovirus)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YGL123C-A (YGL123C-A)
Ask
View Details